{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:32:43Z","timestamp":1785713563248,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jep.2021.114078","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T03:03:37Z","timestamp":1617073417000},"page":"114078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Xinyang Tablet inhibits MLK3-mediated pyroptosis to attenuate inflammation and cardiac dysfunction in pressure overload"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-2225","authenticated-orcid":false,"given":"Junyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongkai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxiang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-5182","authenticated-orcid":false,"given":"Lingjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvx221","article-title":"Local production of tenascin-C acts as a trigger for monocyte\/macrophage recruitment that provokes cardiac dysfunction","volume":"114","author":"Abbadi","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.jep.2021.114078_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.jep.2021.114078_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2018.03.004","article-title":"The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: applications to drug discovery","volume":"129","author":"Afratis","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jep.2021.114078_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrcardio.2012.37","article-title":"Novel biomarkers in chronic heart failure","volume":"9","author":"Ahmad","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib5","doi-asserted-by":"crossref","first-page":"H145","DOI":"10.1152\/ajpheart.00029.2018","article-title":"Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload","volume":"316","author":"Calamaras","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.jep.2021.114078_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fphys.2018.01333","article-title":"Inhibiting receptor of advanced glycation end products attenuates pressure overload\u2013induced cardiac dysfunction by preventing excessive autophagy","volume":"9","author":"Gao","year":"2018","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.jep.2021.114078_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2967\/jnumed.119.232488","article-title":"Multimodality imaging of inflammation and ventricular remodeling in pressure-overload heart failure","volume":"61","author":"Glasenapp","year":"2020","journal-title":"J. Nucl. Med. : Off. Publ. Soc. Nucl. Med."},{"issue":"3","key":"10.1016\/j.jep.2021.114078_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13105-017-0561-5","article-title":"Protective role of downregulated MLK3 in myocardial adaptation to chronic hypoxia","volume":"73","author":"He","year":"2016","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.jep.2021.114078_bib10","first-page":"261","article-title":"A clinical study of Baoxinkang for congestive heart failure with qi-and-yang -deficiency syndrome","volume":"5","author":"Huang","year":"2000","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"key":"10.1016\/j.jep.2021.114078_bib11","first-page":"220","article-title":"Effects of Xinyang Tablet on brain natriuretic peptide, hypersensitive C-reactive protein and cardiac function in patients with acute decompensated heart failure","volume":"22","author":"Hui","year":"2011","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"key":"10.1016\/j.jep.2021.114078_bib12","first-page":"2604","article-title":"Effects and mechanism of Xinyang Tablet on inhibiting cardiomyocyte cell ferroptosis mediated by MLK3\/JNK\/p53 and preventing chronic heart failure","volume":"35","author":"Junyan","year":"2020","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"issue":"6","key":"10.1016\/j.jep.2021.114078_bib13","doi-asserted-by":"crossref","first-page":"H1237","DOI":"10.1152\/ajpheart.00004.2019","article-title":"Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy","volume":"316","author":"Kar","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jep.2021.114078_bib14","doi-asserted-by":"crossref","first-page":"105168","DOI":"10.1016\/j.phrs.2020.105168","article-title":"Traditional Chinese medicine in cardiovascular drug discovery","volume":"160","author":"Leung","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvq272","article-title":"Cardiac mast cells: the centrepiece in adverse myocardial remodelling","volume":"89","author":"Levick","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCRESAHA.119.316364","article-title":"Inflammasomes and proteostasis novel molecular mechanisms associated with atrial fibrillation","volume":"127","author":"Li","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.jep.2021.114078_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10557-020-06995-x","article-title":"Protection of sacubitril\/valsartan against pathological cardiac remodeling by inhibiting the NLRP3 inflammasome after relief of pressure overload in mice","volume":"34","author":"Li","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"9","key":"10.1016\/j.jep.2021.114078_bib18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2165\/00003495-200161090-00002","article-title":"Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications","volume":"61","author":"Li","year":"2001","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","article-title":"Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases","volume":"113","author":"Liu","year":"2018","journal-title":"Basic Res. Cardiol."},{"issue":"8","key":"10.1016\/j.jep.2021.114078_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038074","volume":"10","author":"Long","year":"2020","journal-title":"BMJ open"},{"key":"10.1016\/j.jep.2021.114078_bib21","first-page":"276","article-title":"Effect of Xinyang tablet on improving cardiac function in mice with heart failure by inhibiting autophagy of cardiomyocytes","volume":"31","author":"Lu","year":"2020","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"issue":"036","key":"10.1016\/j.jep.2021.114078_bib22","article-title":"Imaging interstitial fibrosis, left ventricular remodeling, and function in stage A and B heart failure","volume":"05","author":"Pezel","year":"2020","journal-title":"JACC Cardiovasc. Imag."},{"key":"10.1016\/j.jep.2021.114078_bib23","doi-asserted-by":"crossref","first-page":"107511","DOI":"10.1016\/j.pharmthera.2020.107511","article-title":"Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis","volume":"209","author":"Pinar","year":"2020","journal-title":"Pharmacol. Therapeut."},{"issue":"21","key":"10.1016\/j.jep.2021.114078_bib24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jep.2021.114078_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-021119-034412","article-title":"New approaches to target inflammation in heart failure: harnessing insights from studies of immune cell diversity","volume":"82","author":"Rhee","year":"2020","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"10.1016\/j.jep.2021.114078_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108487","article-title":"Pharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft model","volume":"9","author":"Rhoo","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jep.2021.114078_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2017.02.026","article-title":"The role of chemokines in hypertension and consequent target organ damage","volume":"119","author":"Rudemiller","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11481-018-09829-8","article-title":"Broad spectrum mixed lineage kinase type 3 inhibition and HIV-1 persistence in macrophages","volume":"14","author":"Saminathan","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"8","key":"10.1016\/j.jep.2021.114078_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-Mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.jep.2021.114078_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail. Rev."},{"issue":"9792","key":"10.1016\/j.jep.2021.114078_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(11)60894-5","article-title":"In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.","volume":"378","author":"Shah","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12265-020-10049-w","article-title":"Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction","volume":"14","author":"Silvis","year":"2020","journal-title":"J. Cardiovasc. Transl. Resear."},{"issue":"8","key":"10.1016\/j.jep.2021.114078_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jep.2021.114078_bib34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.jep.2021.114078_bib35","first-page":"609","article-title":"Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury via eNOS-dependent mechanism","volume":"113","author":"Valle Raleigh","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.jep.2021.114078_bib36","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.jep.2021.114078_bib37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41419-020-02777-3","article-title":"Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jep.2021.114078_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cca.2020.06.044","article-title":"Pyroptosis: a pro-inflammatory type of cell death in cardiovascular disease","volume":"510","author":"Wang","year":"2020","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.jep.2021.114078_bib39","doi-asserted-by":"crossref","first-page":"112536","DOI":"10.1016\/j.jep.2019.112536","article-title":"Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats","volume":"252","author":"Wang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jep.2021.114078_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","article-title":"IL-18 cleavage triggers cardiac inflammation and fibrosis upon \u03b2-adrenergic insult","volume":"39","author":"Xiao","year":"2018","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.jep.2021.114078_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00758-19","article-title":"High-throughput screening identifies mixed-lineage kinase 3 as a key host regulatory factor in zika virus infection","volume":"93","author":"Xu","year":"2019","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.jep.2021.114078_bib42","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging activators and regulators of inflammasomes and pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jep.2021.114078_bib43","first-page":"3231424","article-title":"The role of traditional Chinese medicine in the regulation of oxidative stress in treating coronary heart disease","author":"Yang","year":"2019","journal-title":"Oxid. Med. Cel. Longev."},{"issue":"20","key":"10.1016\/j.jep.2021.114078_bib44","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.jep.2021.114078_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012884","article-title":"Characteristics, management, and outcomes of patients hospitalized for heart failure in China: the China PEACE retrospective heart failure study","volume":"8","author":"Yu","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.jep.2021.114078_bib46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.7150\/ijbs.33568","article-title":"Role of pyroptosis in cardiovascular diseases and its therapeutic implications","volume":"15","author":"Zeng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.jep.2021.114078_bib47","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","article-title":"Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.jep.2021.114078_bib48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874121003056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874121003056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:09:20Z","timestamp":1759943360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874121003056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"alternative-id":["S0378874121003056"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2021.114078","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xinyang Tablet inhibits MLK3-mediated pyroptosis to attenuate inflammation and cardiac dysfunction in pressure overload","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2021.114078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114078"}}